slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 5,761-5,790
Pages 350
Rows per page 30
Slide type
5,761-5,790 of 10,471
04
Includes a footer disclaimer regarding non-GAAP measures.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
07
Includes a grid of photos of various Soho House locations.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
Includes a disclaimer about non-GAAP measures at the bottom left.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
Includes non-GAAP financial measures disclaimer.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Beat · Financials1 hit
13
The slide presents clinical trial data (STAI-G scores) showing significant reduction in anxiety symptoms for the LSD group compared to placebo over 24 weeks.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
24
The chart shows a clear performance gap between placebo and MDMA, supporting the therapeutic potential of the drug.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
06
The slide uses a grouped bar chart format to demonstrate year-over-year growth in operational KPIs.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Loop · Why Now1 hit
24
The slide uses two bar charts to demonstrate financial health and asset-light nature.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
29
ModivCare | Investor Presentation Deck | 36 slidesModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
04
VN likely stands for Verified Neighbors.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Problem1 hit
06
The slide uses a photo of a local business owner to humanize the 'supporting local businesses' metric.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The chart illustrates a positive correlation between market penetration and user engagement.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
12
The chart highlights Nextdoor in green, with other major platforms like Facebook, Snapchat, X, and Pinterest highlighted in their respective brand colors.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
27
The chart uses stacked bars to show geographic segmentation of users over time.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
28
The slide uses two bar charts side-by-side to demonstrate consistent revenue growth over different timeframes.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
29
The slide shows two distinct bar charts side-by-side representing annual and quarterly ARPU trends.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
06
The slide uses a logo grid to establish credibility and market presence.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
08
The slide details a capital raise structure involving senior secured notes and warrants.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
04
The slide combines a retrospective traction report with a mission/vision statement.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
19
The chart displays dose-dependent exposure levels exceeding multiple efficacy targets (ROS1 G2032R and Wild Type in CNS and periphery).Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
20
Clinical trial data presentation for NVL-520.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
21
The chart uses a waterfall plot to visualize clinical efficacy, a standard in oncology drug development.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
22
The chart is a swimmer plot (a common clinical trial visualization).Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
23
Includes clinical trial data (ORR, tumor shrinkage, allele clearance) for a specific drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
24
Includes patient case study images and clinical trial metrics.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
31
The slide compares vehicle control against NVL-655 treatment in both bar chart (multiple models) and line chart (PDX model) formats.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
09
The slide demonstrates superior tumor volume reduction by NXP800 compared to standard-of-care Cisplatin in both SKOV-3 and TOV-21G models.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
Includes a patient-derived xenograft (PDX) study workflow diagram and a tumor volume growth curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The chart shows tumor volume reduction over 28 days compared to vehicle control.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The charts demonstrate efficacy in specific cell lines (KYSE70 and Cal27) with known genetic alterations.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit